Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

350 results
  1. ... observe that the remarks made, will not have reference to the Sars- aparilla alone, but they must be understood as ...
  2. ... William Winkenwerder and Brian Hughes [on terms of reference for a SARS quarantine policy task force] ... William Winkenwerder and Brian Hughes [on terms of reference for a SARS quarantine policy task force] SARS Virus Severe Acute ...
  3. NLM Digital Collections - Enforcement policy for viral transport media during the coronavirus disease 2019 (COVID19) ... 
    Publication: [Silver Spring, MD] : Center for Devices and Radiological Health, November 2021
    ... devices and therefore help expand the availability of SARS-CoV-2 diagnostic testing. This update removes references to certain aspects of the test modification policy ...
  4. NLM Digital Collections - Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2023
    ... i.e., baseline resistance analyses) and (2) identify SARS-CoV-2 genetic changes associated with ... • Sponsors should also reference the guidance for industry COVID-19: Developing Drugs ...
  5. NLM Digital Collections - Demographic characteristics of adults receiving COVID-19 booster vaccinations 
    Publication: Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, March 2022
    ... protect against infection and severe disease caused by SARS-CoV-2, ... their respective reference groups to have received a booster. People aged ...
  6. NLM Digital Collections - COVID-19 : potency assay considerations for monoclonal antibodies and other therapeutic ... 
    Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
    ... Function Assays ......................................................................................... 8 B. Additional Considerations ................................................................................................ 9 IV. References .............................................................................................................................. 9 Contains Nonbinding Recommendations COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity Guidance for Industry This guidance ...
  7. ... 2021). ‘REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in ... on 12 July 2021). References 94 Directors of public health and the Covid- ...
  8. NLM Digital Collections - Family presence during a pandemic : guidance for decision-making family presence during a ... 
    Publication: [McLean, VA] : Institute for Patient and Family-Centered Care, [2021]
    ... 4 Context for ... Appendix 1: An Iterative Process ...
  9. NLM Digital Collections - Protecting participants in bioequivalence studies for abbreviated new drug applications ... 
    Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
    ... the consideration of reducing risk of exposure to SARS-CoV-2. The ... 314.3(b) defining reference listed drug and reference standard, 21 CFR 320. ...
  10. ... Op, Petrol, Plat, Pb, Rhus, Buta, Saba, Sabi, Sars, Seneg, Sep, SIL, Spo, Squ, Stan, Staph, SUL, ... Ran. s. Rheum, Rhodo, Rhus, Ruta, Sabi, Sal. ae, Sars, Sec c, Sep, SIL, Spig, Squ, S'taph, Still, ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last